Galapagos NV - ADR (GLPG) Company Profile & Statistics

Galapagos NV - ADR
GLPG
(Nasdaq - US)
Closed
29.08
+0.17 (+0.59%)
in:usd•As of: Apr 19, 2024 15:59 UTC -4
Open
28.89
High
29.11
Low
28.85

About Galapagos NV - ADR

CEO

Paul Stoffels

Headquarters

gen de wittelaan l11 a3

mechelen, c9 2800, belgium

Auditor

Deloitte Bedrijfsrevisoren

Employees

1,338

Share Holders

N/A

Website

www.glpg.com

Industry

biotechnology

Sector

health technology

Company Overview

Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include GLPG0634 for the treatment of rheumatoid arthritis and other inflammatory diseases, GLPG1205/GLPG1690 for treating inflammatory bowel disease, GSK2586184 for the treatment of chronic immuno-inflammatory diseases and GLPG0974, to prevent free fatty acid-induced activation and migration of neutrophils which are in different clinical trial. Galapagos NV is headquartered in Mechelen, Belgium.

Galapagos NV - ADR Statistics

Valuation Measures

Market Capitalization ²	1.92B
Enterprise Value	1.74B
Enterprise Value/EBITDA (ttm)	-8.55
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.64
Price to Sales (ttm)	3.30
Price to Cash (ytd)	44.88

Profitability

Gross Margin (ttm)	72.88%
Operating Margin (ttm)	-12.34%
Profit Margin (ttm)	-62.36%
Return on Equity (ttm)	-2.60%
Return on Invested Capital (ttm)	-9.29%
Return on Assets (ttm)	-1.46%

Income Statement

Revenue (ttm)	395.18M
Revenue Per Share (ttm)	6.00
Gross Profit (ttm)	384.86M
EBITDA (ttm)³	-203.60M
Net Income Avi to Common (ttm)	-251.38M
Diluted EPS (ttm)	-2.29

Share Statistics

Beta (5Y Monthly)	0.24
52-Week Change	-22.25%
S&P500 52-Week Change	20.28%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	65.90M
Dividend Yield	0.00%
Float ⁴	63.98M
% Held by Insiders	2.91%
% Held by Institutions	32.46%

Balance Sheet

Total Cash (mrq)	3.99B
Total Cash Per Share (mrq)	60.51
Total Debt (mrq)	5.35M
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	N/A
Quick Ratio (mrq)	8.84%
Book Value Per Share (mrq)	N/A

Cash Flow

Operating Cash Flow Per Share (ytd)	N/A
Free Cash Flow (ytd)	0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Galapagos NV - ADR

Trade With A Regulated Broker